1. Home
  2. APGE vs CIGI Comparison

APGE vs CIGI Comparison

Compare APGE & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$132.71

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Colliers International Group Inc. Subordinate Voting Shares

CIGI

Colliers International Group Inc. Subordinate Voting Shares

HOLD

Current Price

$89.89

Market Cap

4.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
CIGI
Founded
2022
1972
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.7B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
APGE
CIGI
Price
$132.71
$89.89
Analyst Decision
Strong Buy
Buy
Analyst Count
13
5
Target Price
$109.67
$176.25
AVG Volume (30 Days)
4.0M
158.5K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
0.29%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.28
Revenue Next Year
N/A
$8.30
P/E Ratio
N/A
$57.57
Revenue Growth
N/A
N/A
52 Week Low
$34.34
$89.05
52 Week High
$133.16
$171.20

Technical Indicators

Market Signals
Indicator
APGE
CIGI
Relative Strength Index (RSI) 81.42 33.97
Support Level $75.41 N/A
Resistance Level N/A $100.28
Average True Range (ATR) 4.21 3.17
MACD 5.57 -0.51
Stochastic Oscillator 99.15 8.93

Price Performance

Historical Comparison
APGE
CIGI

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.

Share on Social Networks: